skip to content

Network of Trophoblastic Diseases of Quebec

Information and support for professionals and patients

  • Mission of the RMTQExpand
    • Operation – RMTQ
    • Team – RMTQ
    • Software – RMTQ
    • Software development
    • Statistics
  • ProfessionalsExpand
    • DiagnosticExpand
      • Clinical classification
      • Post-molar GTN
      • Quiescent GTD
    • ßhCGExpand
      • Elevated ßhCG
      • non-GTN tumor hCG
      • Differential dx hCG
      • ßhCG – normal pregnancy
    • FIGO stages and scoresExpand
      • FIGO Stadiums
      • FIGO score
      • GTN Risk Levels
    • Pathology and geneticsExpand
      • Principles of Genetics
      • Origins and phenotypes
      • Moles and abortions
      • EPS, PSN and GTN
    • GTD in numbers
  • GuidelinesExpand
    • ISSTD et al. 2025
    • SOGC/GOC DirectiveExpand
      • Practice Changes
      • Key messages
      • Summary declarations
      • Recommendations
    • Hydatidiform molesExpand
      • Partial/complete moles
      • Post mole follow-up
      • Moles and pregnancies
    • NeoplasiasExpand
      • Low risk GTN
      • GTN ultra/high risk
      • Post-GTN follow-up
      • Recurrent GTNs
    • PSTT and ETT
    • ChemotherapyExpand
      • Monochemotherapy
      • EMA-CO and EMA-EP
      • Polychemotherapies
      • CHUM Chemo Protocols
  • ResearchExpand
    • Rima Slim PhD Lab.
    • Protocols – RMTQ
    • Publications – RMTQ
    • Abbreviations
    • Useful links
  • PatientsExpand
    • Nurse Coordinator
    • Babies – RMTQ
    • Hydatidiform mole – FAQ
    • Malignant disease – FAQ
    • Testimonials
  • French
Facebook Linkedin
Network of Trophoblastic Diseases of Quebec
Information and support for professionals and patients

Maupiti – Polynésie

Liens utiles

OrganisationsPays/SociétésLangues
International Society for the Study of Trophoblastic DiseasesISSTDAnglais
European Organisation for Treatment of Trophoblastic DiseasesEOTTDAnglais
Centre de référence des maladies trophoblastiquesFranceFrench
Centre des maladies trophoblastiques de SuisseSuisseFrançais, Allemand
Hydatiform mole and Choriocarcinoma UK Support and Information ServiceUKAnglais
The Sheffield Trophoblastic Disease CentreUKAnglais
Support, sharing of experience, informationUKAnglais
Memorial Sloan-Kettering Cancer CenterUSAAnglais
John I. Brewer Trophoblastic Disease CenterUSAAnglais

Modified on 12/23/2023

Tropho News

6 new deleterious variants identified in androgenetic hydatidiform moles!

Read more ...
FIGO score calculation Declare your patient To contact us
  • Make a donation
  • Sitemap
  • Legal Notice
  • Confidentiality

Quebec badge

Eco -responsible accommodation badge

© 2026 Réseau des Maladies Trophoblastiques du Québec - Tous droits réservés

Scroll to top
  • Mission of the RMTQ
    • Operation – RMTQ
    • Team – RMTQ
    • Software – RMTQ
    • Software development
    • Statistics
  • Professionals
    • Diagnostic
      • Clinical classification
      • Post-molar GTN
      • Quiescent GTD
    • ßhCG
      • Elevated ßhCG
      • non-GTN tumor hCG
      • Differential dx hCG
      • ßhCG – normal pregnancy
    • FIGO stages and scores
      • FIGO Stadiums
      • FIGO score
      • GTN Risk Levels
    • Pathology and genetics
      • Principles of Genetics
      • Origins and phenotypes
      • Moles and abortions
      • EPS, PSN and GTN
    • GTD in numbers
  • Guidelines
    • ISSTD et al. 2025
    • SOGC/GOC Directive
      • Practice Changes
      • Key messages
      • Summary declarations
      • Recommendations
    • Hydatidiform moles
      • Partial/complete moles
      • Post mole follow-up
      • Moles and pregnancies
    • Neoplasias
      • Low risk GTN
      • GTN ultra/high risk
      • Post-GTN follow-up
      • Recurrent GTNs
    • PSTT and ETT
    • Chemotherapy
      • Monochemotherapy
      • EMA-CO and EMA-EP
      • Polychemotherapies
      • CHUM Chemo Protocols
  • Research
    • Rima Slim PhD Lab.
    • Protocols – RMTQ
    • Publications – RMTQ
    • Abbreviations
    • Useful links
  • Patients
    • Nurse Coordinator
    • Babies – RMTQ
    • Hydatidiform mole – FAQ
    • Malignant disease – FAQ
    • Testimonials
  • French
Search